A new scientific review concludes that acidic cannabinoids including THCA, CBDA and CBGA are pharmacologically active compounds with potential therapeutic relevance across a range of …
Oregon Marijuana Sales Reach $74.7 Million in September, $683 Million in 2026, as Concentrate Prices Drop to Record Low of $14.58 Per Gram
Oregon’s legal marijuana market generated $74,656,873 in sales in September, bringing the state’s total for the first nine months of 2026 to more than $683.5 …
Survey of 818 People With Rheumatic and Musculoskeletal Diseases Finds 80% of Current Marijuana Users Report Less Pain, 74% Better Sleep
A survey of more than 800 people with rheumatic and musculoskeletal diseases found that nearly 80% of current marijuana consumers reported that marijuana reduced their …
Utah Medical Cannabis Sales Reach $16.7 Million in September, Bringing 2026 Total to $151.5 Million, Up 16% From 2025
Utah medical cannabis sales reached $16.7 million in September, bringing the state’s total for 2026 to approximately $151.5 million, according to the newest monthly report …
“Odourless” Marijuana Product Expands to More Than 300 Retailers Months After Launch
A marijuana product marketed as “odourless” is now stocked, ordered or being added by more than 300 licensed retailers across Ontario, just months after launching …
Daily Cannabis News Brief for 10/2/2026
Below is The Marijuana Herald’s Daily Cannabis News Brief for October 2, 2026, sponsored by Trulieve. The Marijuana Herald publishes a new edition every weekday …
Connecticut Now Requires Certain Marijuana Products to Be Reserved for Medical Patients for 14 Days Before Adult-Use Sale
Connecticut marijuana businesses must now reserve certain products exclusively for medical patients for 14 days before making them available to adult-use consumers, with newly issued …
Study: CBD Use Among Adults 65 and Older Associated With Less Pain and Depression, Better Quality of Life and Fewer Hospital Admissions
A new study of adults 65 and older found that cannabidiol (CBD) users reported significantly less pain and depression, better quality of life and fewer …
IRS and Department of Treasury Make Section 280E Marijuana Tax Guidance an Official Federal Priority for 2026–27
The Internal Revenue Service (IRS) and U.S. Department of the Treasury have formally made guidance on Section 280E a federal priority for the coming year, …
New York Approves Research License for First U.S. Human Trial of Cannabis-Based VER-01 for Chronic Pain
New York regulators have approved a cannabis research license allowing a Williamsville laboratory to participate in the first U.S. human clinical trial of VER-01, an …
Curaleaf’s Liquid Medical Marijuana Inhaler Becomes First of Its Kind Registered in Australia
Curaleaf International says its liquid medical marijuana inhalation device has become the first of its kind to receive regulatory approval in Australia, following its inclusion …
Survey: Marijuana Investors Put 65% Odds on Federal Rescheduling Within Six Months, 47% More Bullish Than Six Months Ago
Marijuana investors remain broadly optimistic about federal rescheduling despite continued uncertainty surrounding the process, with a new survey finding investors assigned a 65% probability to …
